Pediatr Hematol Oncol
December 2024
Hospitalized patients with sickle cell disease (SCD) may use opioid medications for both acute and chronic pain management. Use of these medications may unintentionally generate diagnostic codes for opioid misuse including "opioid use," "opioid abuse," and "opioid dependence," which connote a behavioral problem or addiction. In this study, we sought to compare diagnostic codes for opioid misuse amongst hospitalized patients with and without SCD.
View Article and Find Full Text PDFThis study presents a significant advancement in tandem dye-sensitized solar cells (T-DSSCs) through the strategic synthesis of novel triazatruxene (TAT) sensitizers MS-1 and MS-2. These organic sensitizers demonstrate exceptional light-harvesting capacity and overall performance, pushing the boundaries of power conversion efficiency (PCE) in DSSCs. The MS-1-based DSSCs achieved an impressive PCE of 12.
View Article and Find Full Text PDFPainimation, a novel digital pain assessment tool, allows patients to communicate their pain quality, intensity, and location using abstract animations (painimations) and a paintable body image. This study determined the construct validity of painimations and body image measures by testing correlations with validated pain outcomes in adults with sickle cell disease (SCD). Analyses used baseline data from a multisite randomized trial of 359 adults with SCD and chronic pain.
View Article and Find Full Text PDF